Mortality and Heart Failure Risk Reductions in Patients Treated With Sacubitril–Valsartan in Clinical Trials : American Journal of Therapeutics

Secondary Logo

Journal Logo

You can read the full text of this article if you:

Access through Ovid
Letters to the Editor

Mortality and Heart Failure Risk Reductions in Patients Treated With Sacubitril–Valsartan in Clinical Trials

Cordero, Alberto MD, PhD, FESC1,2; Nuñez, Julio MD, PhD, FESC2,3; Bertomeu-González, Vicente MD, PhD, FESC1,2; Fácila, Lorenzo MD, PhD4; Quintanilla, Mª Amparo MD, PhD1; Rodríguez-Mañero, Moisés MD, PhD2,5; Escribano, David MD1; Valle, Alfonso MD, PhD6; de la Espriella, Rafael MD, PhD2,3; Torres-Llergo, Javier MD7; Bayés-Genís, Antoni MD, PhD, FESC2,8; González-Juanatey, José R. MD, PhD, FESC, FACC2,5

Author Information
doi: 10.1097/MJT.0000000000001503
  • Buy
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.